We serve Chemical Name:2-phenylpentan-2-ol CAS:4383-18-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-phenylpentan-2-ol
CAS.NO:4383-18-0
Synonyms:2-Oxy-2-phenyl-pentan;MFCD00046592;2-Phenyl-2-pentanol;2-PHENYL-PENTAN-2-OL
Molecular Formula:C11H16O
Molecular Weight:164.24400
HS Code:2906299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:216ºC at 760 mmHg
Density:0.965g/cm3
Index of Refraction:1.509
PSA:20.23000
Exact Mass:164.12000
LogP:2.69420
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Oxy-2-phenyl-pentan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-PHENYL-PENTAN-2-OL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Oxy-2-phenyl-pentan Use and application,2-Phenyl-2-pentanol technical grade,usp/ep/jp grade.
Related News: In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. 2-phenylpentan-2-ol manufacturer The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. 2-phenylpentan-2-ol supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. 2-phenylpentan-2-ol vendor With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 2-phenylpentan-2-ol factory The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.
